XX BIO
Live / Allowed — Published for opposition (as of 10 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99207737
- Mark type
- Stylized text
- Filed
- 29 May 2025
- Published for opposition
- 10 Feb 2026
- Attorney of record
- Ava R. Shelby
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of heart, cardiovascular, lymphatic, immune, endocrine, autoimmune, brain, bone, muscle, skin, cerebrovascular, reproductive, metabolic, ovarian, uterine, mental health, and age and menopause-related diseases in the field of women's health; pharmaceutical preparations for the treatment of heart, cardiovascular, lymphatic, immune, endocrine, autoimmune, brain, bone, muscle, skin, cerebrovascular, reproductive, metabolic, ovarian, uterine, mental health, and age and menopause-related diseases in the field of women's health; biological preparations for medical and pharmaceutical use, namely, for the treatment of heart, cardiovascular, lymphatic, immune, endocrine, autoimmune, brain, bone, muscle, skin, cerebrovascular, reproductive, metabolic, ovarian, uterine, mental health, and age and menopause-related diseases in the field of women's health; diagnostic biomarker reagents for medical purposes for use in treating diseases in the field of women's health; diagnostic reagents for medical purposes; diagnostic preparations for medical purposes; diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; medical diagnostic test strips for blood, urine, and saliva analysis for use in the field of women's health; hormone replacement therapy preparations
- Class 010 — Medical apparatus: Medical devices for treating age and menopause-related diseases and heart, cardiovascular, lymphatic, immune, endocrine, autoimmune, brain, bone, muscle, skin, cerebrovascular, reproductive, metabolic, ovarian, uterine, mental health, and age and menopause-related diseases that only occur or present differently in women; medical diagnostic apparatus for detecting age and menopause-related diseases and diseases that only occur or present differently in women; medical ultrasound apparatus; ultrasound diagnostic apparatus; medical imaging apparatus; medical devices for monitoring heart rate, blood pressure, blood properties, vital signs, respiratory events, and body temperature; medical devices for monitoring psychological conditions; medical products in the nature of devices for treating and diagnosing age and menopause-related diseases and heart, cardiovascular, lymphatic, immune, endocrine, autoimmune, brain, bone, muscle, skin, cerebrovascular, reproductive, metabolic, ovarian, uterine, mental health, and age and menopause-related diseases that only occur or present differently in women; medical diagnostic apparatus for detecting diseases in the field of women's health
- Class 042 — Scientific and technological services: Drug discovery services in the field of women's health; scientific research in the nature of conducting clinical trials for others in the field of women's health; biotechnology research in the field of women's health; research and development services in the field of diagnostic preparations
Owner
- XX BIO, INC., Palo Alto, CA, US
- XX BIO, INC., Palo Alto, CA, US
Prosecution history
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
- 14 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Jan 2026 — EXAMINERS AMENDMENT E-MAILED
- 14 Jan 2026 — EXAMINERS AMENDMENT -WRITTEN
- 13 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Nov 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Nov 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED